Employment history

*2020 – present: Owner Sunville Patents Bv and in that position she is assigned to Arnold & Siedsma as patent attorney.
2018 – 2020: Belgian and European Patent Attorney at LC Patents
2014 – 2018: European Patent Attorney at LC Patents
2009 – 2014: Trainee Patent Attorney at LC Patents
2004 – 2010: PhD – Medical Sciences at KU Leuven

Education

2004-2010: PhD – Medical Scienceschappen (KU Leuven)
2001-2003: Master Biotechnology (UGent)
1999-2001: Bachelor Chemistry (UHasselt)

Languages

Dutch, English, German

Outside activities and memberships

Member of EPI

Publications

Van Gool B, Storck SE, Reekmans S, Lechat B, Gordts PLSM, Pradier L, Pietrzik CU, Roebroek AJM. “LRP1 Has a Predominant Role in Production over Clearance of Ab in a Mouse Model of Alzheimer’s Disease.” Molecular Neurobiology. 2019 Apr 19

Reekmans S., “Is there a Future for Medical/Diagnostic Patents in the US?.”- In: International Pharmaceutical Industry, Vol.5 Issue 1 (2013), p. 20-21

Roebroek AJ, Gordts PL, Reekmans S.,”Generation of a series of knock-in alleles using RMCE in ES cells”, Methods Mol Biol. 2011; 693: 277-81

Roebroek AJ, Gordts PL, Reekmans S.,”Knock-in approaches”, Methods Mol Biol. 2011; 693: 257-75

Reekmans S, Pflanzner T, Gordts PL, Isbert S, Zimmermann P, Annaert W, Weggen S, Roebroek AJ, Pietrzik CU.,”Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis”, Cell Mol Life Sci. 2010 Jan; 67(1): 135-45

Gordts PL, Reekmans S, Lauwers A, Van Dongen A, Verbeek L, Roebroek AJ.,”Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis”, Arterioscler Thromb Vasc Biol., 2009 Sep; 29(9): 1258-64

Roebroek AJ, Reekmans S, Lauwers A, Feyaerts N, Smeijers L, Hartmann D., “Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal fetal Development”, Mol Cell Biol. 2006 Jan;26(2):605-16